Showing results (271-280 of 301) with videos related to

Sort By:
Pageof 31
International Journal of Urology : Official Journal of the Japanese Urological Association|December 19, 2023
Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational studyWataru Fukuokaya, Yuhei Koike, Yuji Yata, et al.
International Journal of Clinical Oncology|July 27, 2026
Timing-dependent skin toxicity phenotypes during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinomaMamoru Hashimoto, Lan Inoki, Yutaka Yamamoto, et al.
Nature Communications|August 29, 2020
Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantationJasper Iske, Midas Seyda, Timm Heinbokel, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 30, 2023
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart reviewJunji Yonese, Nobuyuki Hinata, Satoru Masui, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 31, 2026
Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World PopulationYuto Matsushita, Yuki Kita, Shoichioro Mukai, et al.
The Journal of Allergy and Clinical Immunology|February 23, 2018
Mast cells regulate CD4+ T-cell differentiation in the absence of antigen presentationHector Rodriguez Cetina Biefer, Timm Heinbokel, Hirofumi Uehara, et al.
Urologic Oncology|March 29, 2022
Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitorsWataru Fukuokaya, Takahiro Kimura, Kazumasa Komura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 2, 2024
Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study)Taketo Kawai, Hideyasu Matsuyama, Keita Kobayashi, et al.
Pageof 31